Tracy Tucker

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

Journal: Blood

Published: June 03, 2024

Enhancing clinical genomic accuracy with panelGC: a novel metric and tool for quantifying and monitoring GC biases in hybridization capture panel sequencing.

Enhancing clinical genomic accuracy with panelGC: a novel metric and tool for quantifying and monitoring GC biases in hybridization capture panel sequencing.

Journal: Briefings in bioinformatics

Published: April 12, 2024

ALK+ hyaline vascular Castleman disease: a new kid on the block.

ALK+ hyaline vascular Castleman disease: a new kid on the block.

Journal: Histopathology

Published: December 21, 2021

A Case of ALK-Rearranged Combined Lung Adenocarcinoma and Neuroendocrine Carcinoma with Diffuse Bone Metastasis and Partial Response to Alectinib.

A Case of ALK-Rearranged Combined Lung Adenocarcinoma and Neuroendocrine Carcinoma with Diffuse Bone Metastasis and Partial Response to Alectinib.

Journal: Current oncology (Toronto, Ont.)

Published: December 11, 2021

Diffuse large B-cell lymphoma versus Burkitt lymphoma with discordant diagnostic cytogenetics: Morphology trumps.

Diffuse large B-cell lymphoma versus Burkitt lymphoma with discordant diagnostic cytogenetics: Morphology trumps.

Journal: EJHaem

Published: September 27, 2021

Primary pure carcinoid tumor of the testis: Radiology, pathology and molecular correlation.

Primary pure carcinoid tumor of the testis: Radiology, pathology and molecular correlation.

Journal: Urology case reports

Published: July 02, 2021

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer.

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 23, 2021

Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.

Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.

Journal: Journal of medical genetics

Published: January 25, 2021

Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers.

Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers.

Journal: Clinical and translational gastroenterology

Published: January 16, 2021

Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.

Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.

Journal: The Journal of molecular diagnostics : JMD

Published: November 06, 2020

Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada.

Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada.

Journal: Leukemia research

Published: October 02, 2020

EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes.

EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes.

Journal: Translational lung cancer research

Published: September 21, 2020

Showing 1-12 of 31

Last Updated: 09/26/2026